SCHEMBL8527278

SCHEMBL8527278

C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H](C(=C)CO)CC[C@@H]23)C[C@@H](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)C[C@@H]1O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 12/20 0.42
▸ CYP24A1 Q07973 5/20 0.40
▸ CYP27B1 O15528 1/20 0.40
▸ MAPT P10636 2/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ GC P02774 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ RXRA P19793 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ OPRD1 P41143 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8529292 1.00 VDR (0.42) VDRCYP24A1CYP27B1MAPTNR1I2
SCHEMBL9009445 0.90 VDR (0.41) VDRCYP24A1MAPTNR1I2ABCB11
SCHEMBL8992982 0.90 VDR (0.40) VDRCYP24A1CYP27B1MAPTNR1I2
SCHEMBL8527414 0.90 VDR (0.41) VDRCYP24A1CYP27B1MAPTNR1I2
SCHEMBL8992758 0.89 VDR (0.42) VDRCYP24A1CYP27B1MAPTNR1I2
SCHEMBL9009438 0.88 VDR (0.40) VDRCYP24A1CYP27B1
SCHEMBL9009452 0.88 VDR (0.40) VDRCYP24A1MAPTNR1I2ABCB11
SCHEMBL9009408 0.87 VDR (0.39) VDRCYP24A1MAPTNR1I2ABCB11
SCHEMBL8529675 0.87 VDR (0.39) VDRCYP24A1CYP27B1MAPTNR1I2
SCHEMBL9009440 0.87 VDR (0.45) VDRCYP24A1MAPTNR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647219-B1 DERIVATIVES IN THE VITAMIN D SERIES MODIFIED AT THE 20 POSITION, A METHOD OF PREPARING SUCH DERIVATIVES, INTERMEDIATES USED IN THIS METHOD, PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES AND THEIR USE IN THE PREPARATION OF DRUGS SCHERING AG (DE) 1996-07-31 — — EP claimed
EP-0663902-B1 25-CARBOXYLIC ACID DERIVATIVES IN THE VITAMIN D SERIES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN THE MANUFACTURE OF MEDICINES SCHERING AG (DE) 1998-03-11 — — EP disclosed
US-5585368-A SKIN DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 1996-12-17 — — US disclosed
US-5583125-A SKIN DISORDERS, ANTITUMOR AGENTS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 1996-12-10 — — US disclosed
EP-0647219-B1 DERIVATIVES IN THE VITAMIN D SERIES MODIFIED AT THE 20 POSITION, A METHOD OF PREPARING SUCH DERIVATIVES, INTERMEDIATES USED IN THIS METHOD, PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES AND THEIR USE IN THE PREPARATION OF DRUGS SCHERING AG (DE) 1996-07-31 — — EP disclosed
Send feedback